January CHR VOICE Digest

The VOICE is getting an upgrade! Based on feedback from our readers, each month we will be highlighting what we consider the most important news for fertility patients and professionals working in the field. Do you have a topic you would love covered in next month's VOICE? We would love to hear your feedback by emailing ldellere@thechr.com
In this months CHR VOICE, we cover:
Finally, a surrogacy law in New York State
For some time NY state has been one of only three states without laws allowing surrogacy. As of February 15, 2021, the state will join the majority, facilitating legal arrangement of paid surrogacy in New York state and conducting clinical surrogacy in the state within an existing framework that defines the woman who hired the gestational carrier as the birth mother. Read more about the new law here.
A new clinical trial at CHR for women who need growth hormone
Human growth hormone (HGH) has over the last decade returned to popularity in IVF cycles and is increasingly utilized at many IVF centers, including at CHR. The costs of HGH for patients are, however, significant. To potentially save patients thousands of dollars, CHR is announcing a preliminary trial of a drug called Semorelin, which releases endogenous HGH from the pituitary. Read more about how to qualify for the study here.
First class–action lawsuit because of PGT-A
One could argue that a class-action lawsuit regarding preimplantation genetic testing for aneuploidy (PGT-A) had to happen sooner or later. According to press reports, plaintiffs’ claims are that the two IVF centers may have incorrectly classified potentially healthy embryos as abnormal and, therefore, mistakenly discarded healthy embryos, thereby robbing patients of their chances of having children. Read more about the lawsuit here.
Also included in the January VOICE:
- Further evidence that cryopreservation reduces pregnancy chances in IVF
- New insights into immune tolerance
- Paternal age and autism risk in offspring
- Too many Cesarean sections?
- Cannabis use while trying to conceive
- IVF & Society
- COVID-19 & Pregnancy Updates
- Recently published articles at the CHR
Norbert Gleicher, MD, FACOG, FACS
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over
17,800 babies into the world.
DISCOVER YOUR TREATMENT OPTIONS
You Might Also Enjoy...

LGBTQ+ Family Planning: 5 Options for Having a Baby

Tubal Perfusion Pressure (TPP) and Endometriosis: Are They Linked?

Tips for Optimizing Your Fertility Health for Women Over 40

The CHR June Voice
